Related Experiment Video
Updated: Jul 5, 2026

A Two-Step Method for Percutaneous Transhepatic Choledochoscopic Lithotomy
Published on: September 13, 2022
Cholesterol embolization in a renal graft
Undine Ott1, Jens Gerth, Herman-Josef Gröne
1Department of Internal Medicine III, University of Jena, Jena, Germany.
Insights
Cholesterol emboli can affect kidney transplants, causing delayed graft function. However, if the source is the recipient, kidney allograft survival is often good, unlike emboli from the donor.
Area of Science:
- Nephrology
- Transplantation
- Cardiovascular Medicine
Background:
- Cholesterol embolization syndrome (CES) typically affects native kidneys, leading to renal failure.
- CES in renal allografts is uncommon but associated with atherosclerosis in recipients or donors.
- CES can manifest as delayed graft function post-transplantation.
Observation:
- A 65-year-old male recipient experienced delayed graft function in his renal allograft.
- The recipient had significant atherosclerosis in his external iliac artery, a potential source of emboli.
- The patient required temporary dialysis post-transplantation.
Findings:
- A second biopsy confirmed the absence of cholesterol emboli in the allograft.
- Renal function improved, with serum creatinine at 260 micromol/L six months post-transplant.
- Distinguishing the source of emboli (recipient vs. donor) is critical for prognosis.
Implications:
- Cholesterol embolization should be considered in the differential diagnosis of primary renal allograft non-function or dysfunction.
- Recipient-origin emboli are associated with better allograft survival compared to donor-origin emboli.
- Donor-origin emboli may lead to more extensive disease and higher rates of graft loss, possibly due to procurement trauma or donor atherosclerosis.
Abstract:
Cholesterol embolization into native kidneys has a dim prognosis for renal function and frequently leads to irreversible renal failure. Although uncommon, cholesterol embolization may also occur in renal allografts, particularly if either the recipient or the donor has prominent atherosclerosis. We report here on a case of a 65-yr-old man with cholesterol emboli in the renal allograft and delayed graft function. The recipient's arteria iliaca externa was a potential source because of heavy atherosclerosis. The patient was dialysis-dependent for two wk after transplantation. However, renal function improved, no cholesterol emboli were found in a second biopsy of the graft and serum creatinine is 260 micromol/L six months after the transplantation. In the case of primary renal non-function or dysfunction, cholesterol embolization must be considered in the differential diagnosis. If renal cholesterol embolization originates from the recipient, allograft survival is usually good. In contrast, if cholesterol embolization is of donor origin, graft dysfunction and subsequent graft loss are common. The reason for this difference may be the more extensive embolization developing in an atherosclerotic cadaver donor occurring during the organ procurement or the severe trauma leading to death.
Related Concept Videos
Kidney Transplant II: Surgical Procedure
Kidney Transplant I: Introduction
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Kidney Transplant III: Nursing Management
Hemodialysis II: Procedure and Complications